(CB) Chubb - Overview
Exchange: NYSE •
Country: Switzerland •
Currency: USD •
Type: Common Stock •
ISIN: CH0044328745
Stock: Property, Casualty, Reinsurance, Life, Agriculture
Total Rating 60
Risk 71
Buy Signal 0.71
| Risk 5d forecast | |
|---|---|
| Volatility | 18.5% |
| Relative Tail Risk | -6.77% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.70 |
| Alpha | 13.43 |
| Character TTM | |
|---|---|
| Beta | 0.066 |
| Beta Downside | 0.411 |
| Drawdowns 3y | |
|---|---|
| Max DD | 14.35% |
| CAGR/Max DD | 1.44 |
EPS (Earnings per Share)
Revenue
Description: CB Chubb March 05, 2026
Chubb Limited (CB) is a global insurer and reinsurer, offering a broad range of products across six segments. The company provides both commercial and personal property & casualty (P&C) insurance, a core offering in the insurance sector.
Its commercial lines include package policies, workers compensation, and professional liability. Personal lines cover homeowners, automobile, and high-value articles. Agricultural insurance is also a significant offering, providing specialized coverage for crops and farms.
Chubbs overseas general insurance and global reinsurance segments extend its reach internationally. Reinsurance is a critical component of the insurance business model, allowing insurers to transfer risk. The company also underwrites life insurance and related protection and savings products.
For a deeper dive into Chubbs financial performance and market position, consider exploring its detailed analytics on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income: 10.31b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA -1.86 > 1.0 |
| NWC/Revenue: 24.78% < 20% (prev 24.28%; Δ 0.50% < -1%) |
| CFO/TA 0.05 > 3% & CFO 13.52b > Net Income 10.31b |
| Net Debt (-2.47b) to EBITDA (14.13b): -0.17 < 3 |
| Current Ratio: 10.88 > 1.5 & < 3 |
| Outstanding Shares: last quarter (396.5m) vs 12m ago -7.30% < -2% |
| Gross Margin: 33.42% > 18% (prev 0.29%; Δ 3313 % > 0.5%) |
| Asset Turnover: 23.03% > 50% (prev 22.76%; Δ 0.27% > 0%) |
| Interest Coverage Ratio: 18.01 > 6 (EBITDA TTM 14.13b / Interest Expense TTM 764.0m) |
Altman Z'' 1.91
| A: 0.05 (Total Current Assets 16.30b - Total Current Liabilities 1.50b) / Total Assets 272.33b |
| B: 0.25 (Retained Earnings 66.72b / Total Assets 272.33b) |
| C: 0.05 (EBIT TTM 13.76b / Avg Total Assets 259.44b) |
| D: 0.38 (Book Value of Equity 73.76b / Total Liabilities 192.55b) |
| Altman-Z'' Score: 1.91 = BBB |
Beneish M
| DSRI: none (Receivables none/34.49b, Revenue 59.75b/56.12b) |
| GMI: 0.86 (GM 33.42% / 28.76%) |
| AQI: none (AQ_t none / AQ_t-1 none) |
| SGI: 1.06 (Revenue 59.75b / 56.12b) |
| TATA: -0.01 (NI 10.31b - CFO 13.52b) / TA 272.33b) |
| Beneish M-Score: cannot calculate (missing components) |
What is the price of CB shares?
As of March 06, 2026, the stock is trading at USD 332.46 with a total of 1,876,808 shares traded.
Over the past week, the price has changed by -1.62%, over one month by +0.36%, over three months by +13.06% and over the past year by +17.37%.
Over the past week, the price has changed by -1.62%, over one month by +0.36%, over three months by +13.06% and over the past year by +17.37%.
Is CB a buy, sell or hold?
Chubb has received a consensus analysts rating of 3.45.
Therefor, it is recommend to hold CB.
- StrongBuy: 4
- Buy: 5
- Hold: 10
- Sell: 3
- StrongSell: 0
What are the forecasts/targets for the CB price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 337.1 | 1.4% |
| Analysts Target Price | 337.1 | 1.4% |
CB Fundamental Data Overview March 06, 2026
P/E Trailing = 13.0117
P/E Forward = 12.2399
P/S = 2.2055
P/B = 1.7939
P/EG = 2.0075
Revenue TTM = 59.75b USD
EBIT TTM = 13.76b USD
EBITDA TTM = 14.13b USD
Long Term Debt = 15.73b USD (from longTermDebt, two quarters ago)
Short Term Debt = 1.50b USD (from shortTermDebt, two quarters ago)
Debt = 17.23b USD (from shortLongTermDebtTotal, two quarters ago)
Net Debt = -2.47b USD (from netDebt column, last quarter)
Enterprise Value = 146.26b USD (131.50b + Debt 17.23b - CCE 2.47b)
Interest Coverage Ratio = 18.01 (Ebit TTM 13.76b / Interest Expense TTM 764.0m)
EV/FCF = 11.41x (Enterprise Value 146.26b / FCF TTM 12.82b)
FCF Yield = 8.76% (FCF TTM 12.82b / Enterprise Value 146.26b)
FCF Margin = 21.45% (FCF TTM 12.82b / Revenue TTM 59.75b)
Net Margin = 17.26% (Net Income TTM 10.31b / Revenue TTM 59.75b)
Gross Margin = 33.42% ((Revenue TTM 59.75b - Cost of Revenue TTM 39.78b) / Revenue TTM)
Gross Margin QoQ = 49.20% (prev 31.18%)
Tobins Q-Ratio = 0.54 (Enterprise Value 146.26b / Total Assets 272.33b)
Interest Expense / Debt = 1.19% (Interest Expense 205.0m / Debt 17.23b)
Taxrate = 15.84% (597.0m / 3.77b)
NOPAT = 11.58b (EBIT 13.76b * (1 - 15.84%))
Current Ratio = 10.88 (Total Current Assets 16.30b / Total Current Liabilities 1.50b)
Debt / Equity = 0.23 (Debt 17.23b / totalStockholderEquity, last quarter 73.76b)
Debt / EBITDA = -0.17 (Net Debt -2.47b / EBITDA 14.13b)
Debt / FCF = -0.19 (Net Debt -2.47b / FCF TTM 12.82b)
Total Stockholder Equity = 70.18b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.97% (Net Income 10.31b / Total Assets 272.33b)
RoE = 14.69% (Net Income TTM 10.31b / Total Stockholder Equity 70.18b)
RoCE = 16.01% (EBIT 13.76b / Capital Employed (Equity 70.18b + L.T.Debt 15.73b))
RoIC = 13.69% (NOPAT 11.58b / Invested Capital 84.56b)
WACC = 5.96% (E(131.50b)/V(148.73b) * Re(6.61%) + D(17.23b)/V(148.73b) * Rd(1.19%) * (1-Tc(0.16)))
Discount Rate = 6.61% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -33.33 | Cagr: -1.74%
[DCF] Terminal Value 86.72% ; FCFF base≈14.16b ; Y1≈15.13b ; Y5≈18.27b
[DCF] Fair Price = 1362 (EV 530.20b - Net Debt -2.47b = Equity 532.67b / Shares 391.1m; r=5.96% [WACC]; 5y FCF grow 7.60% → 2.90% )
EPS Correlation: 74.55 | EPS CAGR: 19.80% | SUE: 3.34 | # QB: 6
Revenue Correlation: 91.01 | Revenue CAGR: 13.25% | SUE: 3.66 | # QB: 2
EPS next Quarter (2026-06-30): EPS=6.69 | Chg7d=-0.001 | Chg30d=+0.111 | Revisions Net=+9 | Analysts=21
EPS current Year (2026-12-31): EPS=26.83 | Chg7d=-0.006 | Chg30d=+0.397 | Revisions Net=+19 | Growth EPS=+8.2% | Growth Revenue=+5.1%
EPS next Year (2027-12-31): EPS=28.96 | Chg7d=+0.005 | Chg30d=+0.246 | Revisions Net=+5 | Growth EPS=+7.9% | Growth Revenue=+4.9%
[Analyst] Revisions Ratio: +0.69 (11 Up / 2 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 0.3% (Discount Rate 7.9% - Earnings Yield 7.7%)
[Growth] Growth Spread = +4.7% (Analyst 5.0% - Implied 0.3%)
P/E Forward = 12.2399
P/S = 2.2055
P/B = 1.7939
P/EG = 2.0075
Revenue TTM = 59.75b USD
EBIT TTM = 13.76b USD
EBITDA TTM = 14.13b USD
Long Term Debt = 15.73b USD (from longTermDebt, two quarters ago)
Short Term Debt = 1.50b USD (from shortTermDebt, two quarters ago)
Debt = 17.23b USD (from shortLongTermDebtTotal, two quarters ago)
Net Debt = -2.47b USD (from netDebt column, last quarter)
Enterprise Value = 146.26b USD (131.50b + Debt 17.23b - CCE 2.47b)
Interest Coverage Ratio = 18.01 (Ebit TTM 13.76b / Interest Expense TTM 764.0m)
EV/FCF = 11.41x (Enterprise Value 146.26b / FCF TTM 12.82b)
FCF Yield = 8.76% (FCF TTM 12.82b / Enterprise Value 146.26b)
FCF Margin = 21.45% (FCF TTM 12.82b / Revenue TTM 59.75b)
Net Margin = 17.26% (Net Income TTM 10.31b / Revenue TTM 59.75b)
Gross Margin = 33.42% ((Revenue TTM 59.75b - Cost of Revenue TTM 39.78b) / Revenue TTM)
Gross Margin QoQ = 49.20% (prev 31.18%)
Tobins Q-Ratio = 0.54 (Enterprise Value 146.26b / Total Assets 272.33b)
Interest Expense / Debt = 1.19% (Interest Expense 205.0m / Debt 17.23b)
Taxrate = 15.84% (597.0m / 3.77b)
NOPAT = 11.58b (EBIT 13.76b * (1 - 15.84%))
Current Ratio = 10.88 (Total Current Assets 16.30b / Total Current Liabilities 1.50b)
Debt / Equity = 0.23 (Debt 17.23b / totalStockholderEquity, last quarter 73.76b)
Debt / EBITDA = -0.17 (Net Debt -2.47b / EBITDA 14.13b)
Debt / FCF = -0.19 (Net Debt -2.47b / FCF TTM 12.82b)
Total Stockholder Equity = 70.18b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.97% (Net Income 10.31b / Total Assets 272.33b)
RoE = 14.69% (Net Income TTM 10.31b / Total Stockholder Equity 70.18b)
RoCE = 16.01% (EBIT 13.76b / Capital Employed (Equity 70.18b + L.T.Debt 15.73b))
RoIC = 13.69% (NOPAT 11.58b / Invested Capital 84.56b)
WACC = 5.96% (E(131.50b)/V(148.73b) * Re(6.61%) + D(17.23b)/V(148.73b) * Rd(1.19%) * (1-Tc(0.16)))
Discount Rate = 6.61% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -33.33 | Cagr: -1.74%
[DCF] Terminal Value 86.72% ; FCFF base≈14.16b ; Y1≈15.13b ; Y5≈18.27b
[DCF] Fair Price = 1362 (EV 530.20b - Net Debt -2.47b = Equity 532.67b / Shares 391.1m; r=5.96% [WACC]; 5y FCF grow 7.60% → 2.90% )
EPS Correlation: 74.55 | EPS CAGR: 19.80% | SUE: 3.34 | # QB: 6
Revenue Correlation: 91.01 | Revenue CAGR: 13.25% | SUE: 3.66 | # QB: 2
EPS next Quarter (2026-06-30): EPS=6.69 | Chg7d=-0.001 | Chg30d=+0.111 | Revisions Net=+9 | Analysts=21
EPS current Year (2026-12-31): EPS=26.83 | Chg7d=-0.006 | Chg30d=+0.397 | Revisions Net=+19 | Growth EPS=+8.2% | Growth Revenue=+5.1%
EPS next Year (2027-12-31): EPS=28.96 | Chg7d=+0.005 | Chg30d=+0.246 | Revisions Net=+5 | Growth EPS=+7.9% | Growth Revenue=+4.9%
[Analyst] Revisions Ratio: +0.69 (11 Up / 2 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 0.3% (Discount Rate 7.9% - Earnings Yield 7.7%)
[Growth] Growth Spread = +4.7% (Analyst 5.0% - Implied 0.3%)